Munich, Germany

Angela Krackhardt

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Angela Krackhardt: Pioneering Cancer Treatment

Introduction: Angela Krackhardt, an accomplished inventor based in Munich, Germany, has made significant contributions to the field of medical research, particularly in the realm of cancer treatment. With two patents to her name, she is recognized for her innovative work on T cell receptors that target tumor-associated antigens.

Latest Patents: Angela Krackhardt's latest patents focus on the development of allorestricted peptide-specific T cells. These T cell receptors (TCR) are designed to recognize antigenic peptides derived from the tumor-associated antigen FMNL1/KW13.

The invention aims to induce peptide-specific killing of target cells, which represents a promising approach in cancer therapy. Moreover, the invention encompasses the antigenic peptides derived from FMNL1/KW13, antigen-specific T cells containing the TCR, nucleic acid coding for the TCR, and the potential use of these antigen-specific T cells in the manufacture of medicaments to treat malignancies characterized by the overexpression of FMNL1/KW13.

Career Highlights: Angela is currently affiliated with the Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, where her research continues to advance the understanding and treatment of cancer through innovative cellular therapies.

Collaborations: Throughout her career, Angela has collaborated with notable coworkers, including Ingrid Schuster and Dirk H. Busch, contributing to a dynamic research environment that promotes innovation and excellence in the scientific community.

Conclusion: Angela Krackhardt stands out as a remarkable inventor whose dedication to advancing cancer treatments showcases the essential role that innovations play in medicine. Her ongoing work raises the prospect of developing new therapeutic strategies that could significantly improve patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…